Skip to content

Author

Alexa Fernanda Uriostegui Navarro

We have 4 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Pharmacogenomics in Emergency Care: Actionable Genetic Variability, Drug-Related Toxicity, and Precision Prescribing

Pharmacogenomic information showed potential utility for medication selection, dose modification, drug avoidance, risk stratification, and prevention of recurrent adverse events, although its clinical value depends on integration with renal and hepatic function, comorbidities, drug interactions, disease severity, and c...

Dayanna Estefania Fernández Astudillo, Cristian David Castro Hernandez, María Alejandra Galindo Van Strahlen et al. · 0 citations
Review Open access Aug 2026

Early Neuropsychiatric and Cutaneous Manifestations as Sentinel Signs of Systemic Disease

The reviewed evidence showed that systemic lupus erythematosus presented the broadest clinical heterogeneity, while neurological manifestations in Sjögren syndrome may precede classical glandular symptoms.

Jocelyne Keren Hinojosa Villanueva, Luis Felipe Espinal Pérez, Juan José Parra Serpa et al. · 0 citations
Review Open access Aug 2026

Retinal Vascular Biomarkers for Neurovascular and Multiorgan Risk Assessment: From Fundus Imaging to Predictive Oculomics

Retinal imaging may complement conventional vascular-risk assessment by identifying high-risk phenotypes and supporting targeted systemic evaluation, but it should not replace neuroimaging or specialized cardiovascular, neurological, or renal assessment.

Adrian Jhair Flores Equilea, Natalia Restrepo Hinestrosa, Juan José Parra Serpa et al. · 0 citations
Review Open access Jul 2026

CRISPR-Based Genome Editing in Contemporary Clinical Medicine: Therapeutic Translation, Global Challenges and the Future of Precision Medicine

CRISPR has progressed from an experimental genome-engineering technology to a clinically relevant therapeutic platform, although its future impact will depend on the ability to combine molecular precision and durable therapeutic benefit with rigorous safety assessment, responsible governance, and equitable access acros...

Gabriel Alejandro Ortega Moreno, Gerardo Amaya Villagran, A. González et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.